Biohaven

Biohaven's genetic disease drug meets main trial goal
Reuters
Mon, 09/23/24 - 09:48 am
Biohaven
troriluzole
spinocerebellar ataxia
clinical trials
Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Investors Business Daily
Wed, 05/29/24 - 09:27 pm
Biohaven
immune disease
protein degradation
BHV-1300
immune disorders
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
BioPharma Dive
Tue, 11/21/23 - 11:45 am
Biohaven
weightloss
Ozempic
Wegovy
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Further blow for Biohaven as FDA refuses to consider failed rare disease drug for approval
Fierce Biotech
Thu, 07/27/23 - 10:19 am
Biohaven
FDA
troriluzole
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Thu, 06/1/23 - 06:41 pm
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
Biohaven strikes a deal to take TYK2 drugs in a new direction
BioPharma Dive
Thu, 03/23/23 - 09:05 pm
Biohaven
Pfizer
Hangzhou Highlightll
psoriasis
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Endpoints
Thu, 03/16/23 - 09:46 am
Pfizer
migraines
Royalty Pharma
Biohaven
zavegepant
Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval
BioSpace
Fri, 03/10/23 - 11:32 am
Pfizer
Biohaven
FDA
migraines
nasal spray
zavegepant
Zavzpret
Biohaven looks to seize a new opportunity
EP Vantage
Thu, 02/9/23 - 10:33 am
Biohaven
Pfizer
BHV-7000
taldefgrobep alfa
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Fierce Biotech
Wed, 11/9/22 - 10:41 am
Biohaven
Pfizer
funding
epilepsy
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Wed, 10/5/22 - 10:43 am
Pfizer
M&A
Global Blood Therapeutics
Biohaven
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Pfizer
Biohaven
migraines
epilepsy
Biohaven's ALS drug fails to meet study goals
Yahoo/Reuters
Thu, 09/29/22 - 10:07 am
Biohaven
ALS
clinical trials
troriluzole
Intercept, Annovis and Biohaven Advance Late Phase Trials
BioSpace
Mon, 07/11/22 - 12:00 am
Intercept Pharma NASH
Annovis
buntanetap
Parkinson's Disease
Biohaven
taldefgrobep alfa
SMA
How Pfizer CEO Bourla's evening call brought Biohaven back into the M&A fold
Fierce Pharma
Wed, 07/6/22 - 11:01 am
Pfizer
Pfizer CEOs
Albert Bourla
M&A
Biohaven
SEC
Biopharma takeout spend ticks up
EP Vantage
Tue, 07/5/22 - 11:02 am
M&A
biotech
Pfizer
Biohaven
Bristol Myers Squibb
Turning Point Therapeutics
GSK
Affinivax
Sierra Oncology
Halozyme Therapeutics
Antares Pharma
Biohaven's drug for neurological disease fails late-stage study
Yahoo/Reuters
Mon, 05/23/22 - 09:54 am
Biohaven
spinocerebellar ataxia
clinical trials
troriluzole
Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs
Yahoo/Bloomberg
Fri, 05/13/22 - 10:38 am
Pfizer
Biohaven
M&A

Pages